Advertisement
Research Article

Absence of HIV-1 Evolution in the Gut-Associated Lymphoid Tissue from Patients on Combination Antiviral Therapy Initiated during Primary Infection

  • Teresa H. Evering,

    Affiliation: Aaron Diamond AIDS Research Center, an affiliate of the Rockefeller University, New York, New York, United States of America

    X
  • Saurabh Mehandru,

    Affiliation: Aaron Diamond AIDS Research Center, an affiliate of the Rockefeller University, New York, New York, United States of America

    Current address: Department of Medicine, Mount Sinai Medical Center, New York, New York, United States of America

    X
  • Paul Racz,

    Affiliation: Bernhard-Nocht Institut Fur Tropenmedizin, Hamburg, Germany

    X
  • Klara Tenner-Racz,

    Affiliation: Bernhard-Nocht Institut Fur Tropenmedizin, Hamburg, Germany

    X
  • Michael A. Poles,

    Affiliation: Departments of Medicine, Microbiology and Pathology, New York University Medical Center, New York, New York, United States of America

    X
  • Amir Figueroa,

    Affiliation: Aaron Diamond AIDS Research Center, an affiliate of the Rockefeller University, New York, New York, United States of America

    X
  • Hiroshi Mohri,

    Affiliation: Aaron Diamond AIDS Research Center, an affiliate of the Rockefeller University, New York, New York, United States of America

    X
  • Martin Markowitz mail

    mmarkowitz@adarc.org

    Affiliation: Aaron Diamond AIDS Research Center, an affiliate of the Rockefeller University, New York, New York, United States of America

    X
  • Published: February 02, 2012
  • DOI: 10.1371/journal.ppat.1002506

About the Authors

Teresa H. Evering, Saurabh Mehandru, Amir Figueroa, Hiroshi Mohri, Martin Markowitz
Aaron Diamond AIDS Research Center, an affiliate of the Rockefeller University, New York, New York, United States of America
Paul Racz, Klara Tenner-Racz
Bernhard-Nocht Institut Fur Tropenmedizin, Hamburg, Germany
Michael A. Poles
Departments of Medicine, Microbiology and Pathology, New York University Medical Center, New York, New York, United States of America

Corresponding Author

Email: mmarkowitz@adarc.org

Competing Interests

MM serves as a paid consultant for Gilead, Tibotec, Merck and ViiV Healthcare/GlaxoSmithKline. He is also a paid speaker for Gilead and Tibotec and receives Research Support from Gilead. The remaining authors have declared that no competing interests exist.

Author Contributions

Conceived and designed the experiments: MM THE HM. Performed the experiments: THE SM PR KTR MAP AF. Analyzed the data: THE SM PR KTR. Wrote the paper: THE MM.